LEADER 04505nam 2201201z- 450 001 9910557607403321 005 20210501 035 $a(CKB)5400000000045328 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/68520 035 $a(oapen)doab68520 035 $a(EXLCZ)995400000000045328 100 $a20202105d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aNovel Natural-based Biomolecules Discovery for Tackling Chronic Diseases 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 online resource (180 p.) 311 08$a3-0365-0386-2 311 08$a3-0365-0387-0 330 $aNatural-based biomolecules continuously play an important role in novel drug discovery for the treatment of chronic diseases. The development of natural peptide/protein-based, toxin-based, and antibody-based drugs can significantly improve the biomedical efficiency of disease-specific therapy. The focus of this Special Issue of Biomolecules will be on the most recent advances related to novel peptides/proteins, antibodies, and toxins as forms of medicinal therapy. Recent advances in the discovery and development of these natural biomolecules for use in targeted therapy and immunotherapy against chronic diseases (e.g., cancer, diabetes, cardiovascular diseases, and rheumatoid arthritis) will be addressed. The discussion on using novel disease-specific proteins/peptides/toxins/antibodies along with currently available FDA-approved drugs as combinatorial treatments will also be encouraged in this context. Finally, an overview of some of the selected promising natural biomolecules that are potentially able to address the forthcoming challenges in this field will be included. Both research (in particular) and review articles proposing novelties or overviews, respectively, are welcome. 606 $aHumanities$2bicssc 606 $aSocial interaction$2bicssc 610 $aAKT 610 $aamphibian Bowman-Birk inhibitor 610 $aamyloidogenesis 610 $aanionic lipids 610 $aanti-inflammation 610 $aanticancer therapy 610 $aanticancer therapy/cancer treatment 610 $aantifungal 610 $aantioxidant 610 $aapoptosis 610 $aAsteraceae 610 $aAstragalus membranaceus 610 $aBcl-2 family proteins 610 $abinding affinity 610 $abranched-chain fatty acids 610 $acell cycle arrest 610 $acolorectal cancer 610 $aConidiobolus heterosporus 610 $aCOX-2 610 $aDAPK1 610 $adocetaxel 610 $adrug delivery system 610 $adrug design 610 $aendoplasmic reticulum 610 $aF23R variant 610 $afatty acid oxidation 610 $afibroblasts 610 $afucoidan 610 $aG-protein activation 610 $agingiva 610 $ahepatocyte 610 $ahIAPP 610 $aiNOS 610 $ainsulin 610 $ainsulin granules 610 $akynurenines 610 $alignan 610 $alipid metabolism 610 $alung cancer 610 $amolecular cloning 610 $amolecular docking 610 $an/a 610 $anatural-based compound 610 $aNO 610 $aorientin 610 $aPDX-1 610 $apeptides 610 $aperoxisome proliferator-activated receptor ? 610 $aPetasites japonicus 610 $aPGE2 610 $apharmacophore 610 $aPI3K 610 $aPLGA 610 $apomegranate 610 $apost-translational modification 610 $aPPAR? 610 $aprotease inhibitor 610 $aprotein degradation 610 $apunicalagin 610 $aSENP 610 $aSTAT3 610 $aSUMO 610 $asurvivin 610 $atannins 610 $aTat peptide 610 $aunfolded protein response 610 $awound healing 610 $a?-cell cytotoxicity 610 $a?-sheet transitions 610 $a?-opioid receptor 615 7$aHumanities 615 7$aSocial interaction 700 $aKwok$b Hang Fai$4edt$01310431 702 $aKwok$b Hang Fai$4oth 906 $aBOOK 912 $a9910557607403321 996 $aNovel Natural-based Biomolecules Discovery for Tackling Chronic Diseases$93039486 997 $aUNINA